mPharma appoints Kwesi Arhin as new CEO
- Kwesi Arhin has been appointed as the new CEO of mPharma, becoming the first non-founder to take on the role.
- Co-founder Gregory Rockson will transition to Chairman of the Board after leading the company since its inception in 2013.
- mPharma has raised over $90 million, including a $35 million Series D funding round in 2022.
The appointment of Kwesi Arhin as CEO could bring fresh perspectives to mPharma, especially in navigating the challenges of the healthtech sector. However, the recent layoffs and the broader economic pressures highlight the need for a robust strategy to ensure sustainable growth amidst volatility.
